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Objective: Electroencephalographic status epilepticus occurs in 9–35% of comatose
patients after cardiac arrest. Mortality is 90–100%. It is unclear whether (some) seizure
patterns represent a condition in which anti-epileptic treatment may improve outcome,
or severe ischemic damage, in which treatment is futile. We explored current treatment
practice and its effect on patients’ outcome.
Methods:We retrospectively identified patients that were treated with anti-epileptic drugs
from our prospective cohort study on the value of continuous electroencephalography
(EEG) in comatose patients after cardiac arrest. Outcome at 6 months was dichotomized
between “good” [cerebral performance category (CPC) 1 or 2] and “poor” (CPC 3, 4, or
5). EEG analyses were done at 24 h after cardiac arrest and during anti-epileptic treatment.
Unequivocal seizures and generalized periodic discharges during more than 30 min were
classified as status epilepticus.
Results:Thirty-one (22%) out of 139 patients were treated with anti-epileptic drugs (pheny-
toin, levetiracetam, valproate, clonazepam, propofol, midazolam), of whom 24 had status
epilepticus. Dosages were moderate, barbiturates were not used, medication induced
burst-suppression not achieved, and treatment improved electroencephalographic status
epilepticus patterns temporarily (<6 h).Twenty-three patients treated for status epilepticus
(96%) died. In patients with status epilepticus at 24 h, there was no difference in outcome
between those treated with and without anti-epileptic drugs.
Conclusion: In comatose patients after cardiac arrest complicated by electroencephalo-
graphic status epilepticus, current practice includes unstandardized, moderate treatment
with anti-epileptic drugs. Although widely used, this does probably not improve patients’
outcome. A randomized controlled trial to estimate the effect of standardized, aggressive
treatment, directed at complete suppression of epileptiform activity during at least 24 h, is
needed and in preparation.
Keywords: continuous EEG, cardiac arrest, post-anoxic coma, status epilepticus, epileptic seizures, anti-epileptic
drugs, prognosis
INTRODUCTION
Of comatose patients after cardiac arrest, admitted on the inten-
sive care unit, 40–66% never regains consciousness as a result
of diffuse post-anoxic encephalopathy (1–3). In these patients,
a broad spectrum of electroencephalography (EEG) changes
can be observed (4). Electroencephalographic seizures or sta-
tus epilepticus is described in 9–35% (4–7) and is associated
with poor outcome: case fatality was 90–100% in prospec-
tive case series, despite treatment with anti-epileptic drugs
(2, 6, 8–13).
The diagnosis of seizures and status epilepticus on the EEG of
comatose patients after cardiac arrest is controversial (14, 15). It
may consist of unequivocal seizures: generalized spike–wave dis-
charges at 3/s or faster or clearly evolving discharges of any type
at 4/s or faster, either generalized or focal. However, some experts
also consider other rhythmic or periodic patterns, such as gener-
alized or lateralized periodic discharges or rhythmic delta activity,
as seizure activity (16).
It is unclear whether (some) electroencephalographic seizure
patterns in patients with post-anoxic encephalopathy represent
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a condition, which can be treated with anti-epileptic drugs to
improve patients’ outcome, or rather reflect severe ischemic dam-
age, in which treatment is futile (17). Case series have suggested
that in patients with electroencephalographic status epilepticus,
preserved brainstem reactions and EEG reactivity are associated
with a favorable outcome (6). However, it is unclear whether treat-
ment with anti-epileptic drugs reduces the risk of a poor outcome
in these patients. In the only prospective non-randomized inter-
vention study, aggressive treatment up to pentobarbital induced
burst-suppression resulted in a favorable outcome of 6% of
patients with clinically overt or electroencephalographic status
epilepticus (unpublished data). This proportion is approximately
the same as reported in observational studies, irrespective of treat-
ment (6, 10–13). Despite this lack of evidence, most neurologists
treat electroencephalographic seizures and status epilepticus in
comatose patients after cardiac arrest with anti-epileptic drugs.
Increased detection with continuous EEG monitoring has led to
increased prescription (18, 19). However, only one-third treats
these patients equally aggressive to those with clinically overt status
epilepticus (18, 20).
We evaluated current treatment practice, including its effects on
the EEG and patients’ outcome, of seizures and electroencephalo-
graphic status epilepticus on continuous EEG in comatose patients
after cardiac arrest. We used data from our prospective cohort
study on the prognostic value of continuous EEG monitoring on
the intensive care unit.
MATERIALS AND METHODS
PATIENTS
We retrospectively identified patients who were treated with
anti-epileptic drugs (phenytoin, levetiracetam, valproate, clon-
azepam, or barbiturates) for electroencephalographic seizures
or status epilepticus from our prospectively collected cohort of
comatose patients after cardiac arrest, treated with mild therapeu-
tic hypothermia, between June 1, 2010 and March 31, 2013. These
patients were included in a prospective cohort study on the predic-
tive value of continuous EEG on outcome in two teaching hospitals
in the Netherlands. Design, eligibility criteria, and main outcomes
of the first 60 patients that were included in this study have been
published previously (4). In brief, since June 1, 2010, consecutive
adult comatose patients after cardiac arrest, treated with mild ther-
apeutic hypothermia, were included within 12 h after the arrest to
undergo continuous EEG monitoring on the intensive care unit.
Monitoring continued until patients regained consciousness, died,
or up to 5 days. The institutional review board (Medisch Ethis-
che Toetsingscommissie Twente) waived the need for informed
consent for EEG monitoring and follow-up by telephone.
TREATMENT
Comatose patients after cardiac arrest were treated according to
current standard therapy, as described previously (4). In short,
mild therapeutic hypothermia was induced as soon as possible
after the arrest and maintained for 24 h by intravenously admin-
istered cold saline and cooling pads. Propofol, midazolam, or
a combination of these was used for sedation to a level of −4
or −5 at the Richmond Agitation Sedation Scale and discontin-
ued after normothermia had been reached, if possible. Fentanyl,
remifentanil, morphine, or a non-depolarizing muscle relaxant
was used against shivering.
Treatment of epileptiform discharges was not included in the
study protocol. In both hospitals, decisions with regard to treat-
ment of electroencephalographic epileptic phenomena were made
by the treating intensive care physician in consultation with a
neurologist/clinical neurophysiologist. Although both hospitals
adhere to national guidelines for the treatment of epileptic status
in general, there are no guidelines with respect to these EEG phe-
nomena in patients with post-anoxic encephalopathy on the ICU.
This indicates that both the decision to start anti-epileptic treat-
ment, and the choice of the drugs, and the intensity of treatment
were decided by the treating physician. Propofol or midazolam
was identified as anti-epileptic treatment, if dosages were increased
simultaneously with the initiation of treatment with anti-epileptic
drugs.
EEG RECORDINGS
For all recordings, electrodes were applied according to the inter-
national 10/20 system, using 19 channels. Electrode impedances
were kept below 5 kΩ. Sampling frequency was set to 256 Hz. A
Neurocenter EEG system (Clinical Science Systems, Netherlands)
or a Nihon Kohden system (VCM Medical, Netherlands) was used.
Data were stored to disk for off-line analysis.
OUTCOME ASSESSMENT
Outcome assessment was done at 3 and 6 months after car-
diac arrest by telephone by a single investigator (Marleen C.
Tjepkema-Cloostermans), who was blinded for treatment with
anti-epileptic drugs. The primary outcome measure of the study
was the best score on the cerebral performance category (CPC)
within 6 months, dichotomized between “good” (CPC 1 or 2) and
“poor” (CPC 3, 4, or 5). Secondary outcome measures included
mortality.
EEG ANALYSIS
Patients underwent continuous EEG monitoring, starting within
12 h after cardiac arrest, continuing until they regained conscious-
ness, died, or up to 5 days. Real time EEG analysis was done
intermittently by the consulting neurologist at the bedside, two to
three times a day. Treating physicians decided on treatment with
anti-epileptic drugs based on this bedside EEG analysis. However,
at that time, the EEG was not used for decisions with regard to
discontinuation of intensive care treatment.
Standardized, post hoc, off-line EEG analyses were performed
at 24 h after cardiac arrest in automatically selected 5 min epochs.
Additionally, off-line EEG analyses were done at the initiation of
treatment with each anti-epileptic drug, with access to the full
EEG recordings. Epochs at 24 h after cardiac arrest were ana-
lyzed independently by two investigators (Marleen C. Tjepkema-
Cloostermans, Michel J. A. M. van Putten). Selection of the 5 min
epochs was done by the computer and only based on absence of
artifacts. Each epoch was categorized as iso-electric, low voltage,
burst-suppression, diffuse slowing, normal, or epileptiform dis-
charges. Epileptiform discharges included unequivocal, evolving
seizures, and generalized periodic discharges (GPDs). The investi-
gators were blinded for the patient’s clinical condition during the
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registration, the recording time of the epoch, and the patient’s
outcome. In case of disagreement, the final classification was
decided by consensus. All EEGs of patients who had been treated
with anti-epileptic drugs were subsequently reviewed to classify
the EEG pattern at the initiation of the treatment with each addi-
tional anti-epileptic drug and to assess its effects on EEG patterns.
This was done by two observers (Jeannette Hofmeijer, Michel J. A.
M. van Putten), who had access to the complete recordings, but
were blinded for the patients’ outcome. Electroencephalographic
status epilepticus was defined as unequivocal seizures (generalized
spike–wave discharges at 3/s or faster or clearly evolving discharges
of any type at 4/s or faster) or other rhythmic or periodic patterns,
such as generalized or lateralized periodic discharges or rhyth-
mic delta activity, during more than 30 min. Improvement of the
EEG pattern was defined as disappearance of epileptiform dis-
charges for at least 30 min after the start of any anti-epileptic
treatment. Improvement of background pattern was not taken
into account.
STATISTICAL ANALYSIS
The number of patients treated with the various anti-epileptic
drugs, the proportion of patients in whom treatment improved
EEG patterns, and the proportion of patients with a poor outcome
after treatment are presented in a descriptive way for subgroups
according to EEG patterns at the time of treatment initiation.
Patients treated with and without anti-epileptic drugs are com-
pared with regard to poor outcome. These comparisons are done
for subgroups according to the EEG patterns observed at 24 h after
cardiac arrest. Data are presented as proportions and odds ratios,
including corresponding 95% confidence intervals. Comparison
of baseline characteristics was done by Student’s t -test, Chi-square
test, or Fisher’s exact test, where appropriate.
RESULTS
As of March 31, 2013, 139 patients had been included (108 in
Medisch Spectrum Twente and 31 in Rijnstate Hospital, Figure 1).
Baseline characteristics are presented in Table 1. Blinded EEG eval-
uation at 24 h could be performed in 121 patients. Analysis at 24 h
was not possible in 18 patients due to artifacts in the automatically
selected 5 min epochs.
Thirty-one patients (22%) were treated with anti-epileptic
drugs. This treatment was initiated at a median of 47 h after car-
diac arrest (interquartile range 36–76). Drugs and dosages were
phenytoin initial dosage 1000–1500 mg followed by 200–300 mg
daily in two doses, levetiracetam 1000–1500 mg daily in two doses,
valproate initial dosage 1000–1800 mg followed by 1000–1500 mg
daily in two doses, clonazepam single or repeated bolus of 1 mg,
Propofol 200–400 mg/h, or Midazolam 8–10 mg/h. Two patients
were treated with 1, 9 with 2, 13 with 3, 5 with 4, 1 with 5, and
1 with 6 different anti-epileptic drugs. If additional anti-epileptic
drugs were added, previously given medication had not sufficiently
improved epileptic EEG patterns. Treatment with conventional
anti-epileptic drugs continued after discharge from the ICU in
surviving patients. Barbiturates were not used.
Twenty-four of the treated patients fulfilled criteria for elec-
troencephalographic status epilepticus: 3 had evolving seizures,
12 GPDs, and 9 burst-suppression with bursts resembling epilep-
tiform discharges during more than 30 min. Electroencephalo-
graphic status epilepticus, including evolving seizures, GPDs, and
burst-suppression, started at a median of 28 h after cardiac arrest
FIGURE 1 | Flowchart of included patients. GPDs indicate generalized periodic discharges. Burst-suppression patterns consisted of bursts resembling
epileptiform discharges of 1 up to 5 s.
www.frontiersin.org March 2014 | Volume 5 | Article 39 | 3
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hofmeijer et al. Status epilepticus in postanoxic coma
Table 1 | Baseline characteristics of patients treated with and without
anti-epileptic drugs.
Treatment with
anti-epileptic drugs
P -value
Yes (n=31) No (n=108)
Age (mean years±SD) 64±11 65±12 0.6
OHCA 29 95 0.4
Presumed cause of cardiac
arrest
0.7
Cardiac 20 82
Other 5 11
Unknown 6 15
Initial rhythm 0.7
VF 21 76
Asystole 6 17
Bradycardia 2 4
Unknown 2 11
Propofol treatment 28 101 0.7
Propofol dosage (mg/kg/h,
mean±SD)
3.0±0.7 2.8±1.1
Midazolam treatment 9 36 0.9
Midazolam dosage (µg/kg/h,
mean±SD)
211±271 309±252
Fentanyl treatment 17 53 0.4
Fentanyl dosage (µg/kg/h,
mean±SD)
1.6±0.7 1.8±0.8
Remifentanil treatment 9 33 0.8
Remifentanil dosage (µg/kg/h,
mean±SD)
4.7±2.3 4.2±0.7
Morphine treatment 3 23 0.4
Morphine dosage (µg/kg/h,
mean±SD)
331±148 309±119
SD indicates standard deviation; OHCA, out of hospital cardiac arrest; VF,
ventricular fibrillation; dosage, maximum dosage within the first 24 h.
(interquartile range 23–37). Examples are shown in Figures 2
and 3. All 24 identified patients with a status epilepticus were
treated with additional anesthetics: 23 with propofol, 1 with mida-
zolam, and 11 with a combination of propofol and midazolam. In
these patients, treatment improved the EEG patterns up to tem-
porary suppression of epileptiform activity, but never extending
a period of 6 h. Medication induced burst-suppression was never
achieved. All but one patient with status epilepticus, treated with
anti-epileptic drugs, had a poor outcome and died (Table 2).
The only patient with a status epilepticus and a good outcome
(CPC score of 1 at 6 months) had GPDs intermixed with appar-
ently physiological activity. This patient was treated with valproate,
1000 mg/day, and propofol, 2.8 mg/kg/h (Figure 4).
Seven of the treated patients had paroxysmal epileptiform activ-
ity, but not electroencephalographic status epilepticus: five had
short (3–10 s) episodes of rhythmic delta activity, and three had
isolated sharp waves, both superimposed on diffusely slowed, con-
tinuous patterns. These patients all had a good outcome: three had
a CPC score of 1 and 4 of 2 at 6 months (Table 2).
Patients treated with and without anti-epileptic drugs are com-
pared with regard to the risk of poor outcome (Table 3). There
were no statistically significant differences in the subgroup with
status epilepticus at 24 h (evolving seizures or GPDs). Otherwise,
in patients with diffusely slowed or normal EEG patterns at 24 h
after cardiac arrest, the proportion of patients with a poor outcome
was lower after treatment with anti-epileptic drugs.
DISCUSSION
Retrospective analysis of treatment with anti-epileptic drugs in
our prospectively collected cohort of comatose patients after car-
diac arrest demonstrates that unstandardized, moderate treatment
with conventional anti-epileptic drugs, not leading to complete
suppression of epileptiform patterns for longer than 6 h, is com-
mon practice. There was no evidence for a beneficial effect of such
treatment on outcome of patients with electroencephalographic
status epilepticus.
Many of our patients who were treated with anti-epileptic
drugs fulfilled the criteria for status epilepticus by semiology, EEG
appearance, and duration. Still, all were treated only moderately
intensive. In our cohort, moderate treatment indicated that most
patients received solely conventional anti-epileptic drugs in stan-
dard doses. If propofol or midazolam was used, dosages were
never sufficient to suppress epileptiform activity for more than
6 h. Barbiturates were not used and medication induced burst-
suppression was never achieved. A more aggressive treatment
of status epilepticus improves outcome if directed at complete
suppression of electroencephalographic epileptiform discharges
during at least 24 h (21). Whether this holds for status epilepticus
in post-anoxic encephalopathy after cardiac arrest is unknown.
Nevertheless, the moderate character of treatment in our cohort
seems to be common practice and representative for the worldwide
ambivalence toward treatment of electroencephalographic status
epilepticus in this patient group (18, 20). This moderation reflects
the uncertainty with regard to the use of any treatment.
Apart from the intensity of treatment, the onset of treatment
probably plays an important role. With continuous EEG moni-
toring starting 12 h after cardiac arrest, we and others found that
in approximately one-quarter of patients with electroencephalo-
graphic status epilepticus, the epileptiform patterns started before
24 h after cardiac arrest (4, 5, 22). In previous studies, EEG mon-
itoring only started at a median of 2–3 days after cardiac arrest,
indicating that diagnosis and subsequent treatment of electroen-
cephalographic status epilepticus started thereafter at its earliest
(6, 10, 12). In our current study, the median time to onset of
electroencephalographic status epilepticus was 28 h, whereas the
median time to treatment was 47 h. Mechanisms such as excessive
glutamate release are known to worsen brain damage in ongoing
status epilepticus within 20–40 min (23). Also, prolonged dura-
tion of status epilepticus reduces the effect of treatment, e.g., due
to receptor trafficking (24). Thus, the initiation of treatment many
Frontiers in Neurology | Neurocritical and Neurohospitalist Care March 2014 | Volume 5 | Article 39 | 4
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hofmeijer et al. Status epilepticus in postanoxic coma
FIGURE 2 | Examples of EEGs of two comatose patients after cardiac arrest showing generalized periodic discharges. These patients were
normothermic and sedated with propofol 1–2.5 mg/kg/h. The EEG epochs were recorded 46 h (A) or 68 h (B) after cardiac arrest. Filter settings, 0.5–30 Hz.
These patients had a poor outcome.
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FIGURE 3 | Examples of EEGs of two comatose patients after cardiac
arrest showing evolving seizures. These patients were sedated with
propofol 1–2.5 mg/kg/h. The EEG epochs were recorded 19 h after cardiac
arrest, during therapeutic hypothermia (33°C) (A), or 78 h after cardiac arrest,
after restoration of normothermia (B). Filter settings, 0.5–30 Hz. These
patients had a poor outcome.
hours after the onset of electroencephalographic status epilepticus
may be too late to prevent irreversible damage.
Previous studies have focused on electroencephalographic sta-
tus epilepticus as a predictor of poor outcome after cardiac
arrest and the identification of patients in whom treat-
ment of status epilepticus might be beneficial. These have
shown that sporadic patients with post-anoxic encephalopa-
thy after cardiac arrest and electroencephalographic status
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epilepticus may survive (4, 12, 13, 25). Identified possible
determinants of a favorable outcome include a continu-
ous background pattern (25), preserved brainstem reactions,
Table 2 | Proportions of patients with improved EEG or poor outcome
after treatment with (combinations of) anti-epileptic drugs, according
to the EEG pattern at the initiation of treatment.
EEG pattern at initiation Improved EEG Poor outcome
of treatment (n) n (%) n (%)
Evolving seizures (3) 3 (100) 3 (100)
GPD (12) 9 (75) 11 (92)b
Burst-suppressiona (9) 3 (33) 9 (100)
Isolated sharp waves (2) 2 (100) 0
Intermittent rhythmic delta (5) 5 (100) 0
Two patients were treated with 1, 9 with 2, 13 with 3, 5 with 4, 1 with 5, and 1
with 6 different anti-epileptic drugs.
aBurst-suppression patterns consisted of bursts resembling epileptiform dis-
charges of 1 up to 5 s. Complete suppression of epileptiform patterns never lasted
longer than 6 h; EEG, electroencephalography; n.a., not accessible.
bIn the only patient with GPDs and a good outcome, GPDs were intermixed with
apparently physiological activity.
and EEG reactivity (6). However, even in survivors, it
remained unclear whether or not (aggressive) treatment
had improved outcome, since electroencephalographic status
Table 3 | Proportions of patients with poor outcome treated with or
without anti-epileptic drugs according to EEG pattern at 24h after
cardiac arrest.
EEG pattern Poor outcome Poor outcome OR (95% CI)
at 24h with AED without AED
n/N (%) n/N (%)
Iso-electric or low
voltage (n=12)
5/5 (100) 7/7 (100) n.a.
Evolving seizures, GPD,
or burst-suppression
(n=46)
14/17 (82) 23/29 (79) 1.1 (0.4–3.1)
Continuously slowed
(n=61)
0/5 (0) 7/54 (13) 0.9 (0.8–1.0)
AED indicates anti-epileptic drugs; OR, odds ratio of poor outcome of patients
treated with as compared to patients treated without AED; 95% CI, 95%
confidence interval.
FIGURE 4 | Example of an EEG fragment of a comatose patient after
cardiac arrest showing generalized periodic discharges intermixed with
non-rhythmic activity. This patient was sedated with propofol 2.8 mg/kg/h.
The EEG epoch was recorded approximately 40 h after cardiac arrest, after
restoration of normothermia. Filter settings, 0.5–30 Hz. This patient had a
good outcome.
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epilepticus after cardiac arrest is often spontaneously tran-
sient (6).
The evidence of a possible beneficial effect of anti-epileptic
drugs on outcome of patients with relatively favorable EEG pat-
terns is weak, since groups are small and bias by indication, with
selective treatment of patients with a relatively good prognosis,
cannot be excluded. The only neuroprotective treatment of proven
benefit so far in comatose patients after cardiac arrest is mild
therapeutic hypothermia (1). A randomized controlled trial on
the effect of prophylactic treatment with anti-epileptic drugs is
ongoing1.
This study has limitations. First, although data on patient out-
come and EEG patterns were pre-defined and collected prospec-
tively, data on the use of anti-epileptic drugs were retrieved retro-
spectively, implying possible observation or selection bias. Second,
since evidence of effect for treatment with anti-epileptic drugs
is lacking, there was no treatment protocol. Therefore, both the
nature and the intensity of treatment differed among physicians.
However, treatment never reached an intensity to induce burst-
suppression EEG and barbiturates were not used. Third, in patients
who were not treated with anti-epileptic drugs, the presence of
epileptiform EEG patterns was assessed by random checks at 24 h
after cardiac arrest. This indicates that the incidence of epilepti-
form patterns was possibly underestimated. For this reason, com-
parisons between patients treated with and without anti-epileptic
drugs presented in Table 3 should be interpreted with caution.
Fourth, although the Glasgow Coma Scale score was measured
daily, information on other clinical parameters had not been col-
lected prospectively, and retrospective collection appeared unreli-
able. Therefore, the proportion of patients with clinically overt
myoclonic status epilepticus was unclear. However, in patients
after cardiac arrest, for both electroencephalographic seizures and
clinical myoclonia it is not clear whether these represent “true”
seizures, with a possibility to return to physiological activity, or an
expression of severe (irreversible) damage (26). For most neurolo-
gists, the threshold to treat patients with overt myoclonia is lower
than for patients with non-convulsive electroencephalographic
seizures. However, irreversible damage is probably even more likely
in patients with myoclonia, since the risk of poor outcome is larger
(6) and neuronal necrosis is more common (26). Fifth, we selected
patients based on treatment with specific anti-epileptic drugs and
only identified continuously infused propofol or midazolam as
a treatment against electroencephalographic seizures, if dosages
increased simultaneously with the initiation of treatment with
anti-epileptic drugs. We cannot exclude that in some other patients
electroencephalographic seizures were treated solely with propofol
or midazolam.
CONCLUSION
In comatose patients after cardiac arrest with electroencephalo-
graphic status epilepticus, unstandardized treatment with conven-
tional anti-epileptic drugs in standard doses, that only suppresses
pathological EEG patterns temporarily (<6 h), is common prac-
tice. Although widely used, such treatment does probably not
1http://clinicaltrials.gov/ct2/show/NCT01083784
improve patients’ outcome. A randomized controlled trial to esti-
mate the effect of early and aggressive treatment, directed at
complete suppression of epileptiform activity during at least 24 h,
is needed and in preparation (unique identifier NCT02056236)2.
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